« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 120, Issue 6
, Pages
1301-1307
, December 2007
Augmented epithelial endothelin-1 expression in refractory asthma
-
Representative immunostaining of EDN1 in bronchial biopsy specimens from control subjects (A), a patient with mild steroid-untreated asthma (B), and patients with severe steroid-sensitive (C) and ster
Representative immunostaining of EDN1 in bronchial biopsy specimens from control subjects (A), a patient with mild steroid-untreated asthma (B), and patients with severe steroid-sensitive (C) and steroid-refractory (D) asthma is shown. Scale bars = 250 μm. E, proportion of EDN1-positive epithelial cells per millimeter of SBM in bronchial biopsy specimens from control subjects and the 3 groups of asthmatic patients. Bars represent median values, and error bars denote interquartile ranges.
-
Epithelial integrity (A), SBM thickness (B), and ASM areas (C) in bronchial biopsy specimens from control subjects and asthmatic patients are shown. Bars represent median values, and error bars denoteEpithelial integrity (A), SBM thickness (B), and ASM areas (C) in bronchial biopsy specimens from control subjects and asthmatic patients are shown. Bars represent median values, and error bars denote interquartile ranges.
-
Representative immunostaining of fibroblasts and myofibroblasts (propyl-4-hydroxylase–positive cells) in bronchial biopsy specimens from a control subject (A), a patient with mild steroid-untreated asRepresentative immunostaining of fibroblasts and myofibroblasts (propyl-4-hydroxylase–positive cells) in bronchial biopsy specimens from a control subject (A), a patient with mild steroid-untreated asthma (B), and patients with severe steroid-sensitive (C) and refractory (D) asthma is shown. Scale bars = 250 μm. E, Numbers of fibroblasts/myofibroblasts per millimeter of SBM in bronchial biopsy specimens from control subjects and the 3 groups of asthmatic patients. Bars represent median values, and error bars denote interquartile ranges.
Supported in part by the “Agence Nationale de la Recherche,” Paris, France (grant no. 0012405). Sophie Pégorier was funded by the “Chancellerie des Universités de Paris en Sorbonne,” Paris, France.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(07)01780-0
doi: 10.1016/j.jaci.2007.09.023
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 120, Issue 6
, Pages
1301-1307
, December 2007
